返回
N
Ningxia Medical University
学者数7.2K
论文数3.5K
被引数3.7K
关联论文 (2366)
发表时间
HDAC inhibitor tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR-positive HER2-negative advanced breast cancer after CDK4/6 inhibitors treatment: clinical findings and exploratory circulating tumor cell and ctDNA biomarker analyses of a multicenter, phase 2 study (SYSUCC-020 trial)HDAC抑制剂tucidinostat和节拍卡培他滨联合内分泌治疗CDK4/6抑制剂治疗后HR阳性HER2-negative晚期乳腺癌患者: 一项多中心2期研究的临床发现和探索性循环肿瘤细胞和ctDNA生物标志物分析 (SYSUCC-020试验)

